PubRank

P P Sfikakis

Author PubWeight™ 49.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008 3.37
2 Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 2001 2.95
3 Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. Oncogene 2007 1.85
4 Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology (Oxford) 2008 1.83
5 A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis 2011 1.78
6 TNF-α antagonists beyond approved indications: stories of success and prospects for the future. QJM 2010 1.57
7 Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus. Arthritis Rheum 2008 1.51
8 Small airways dysfunction in systemic sclerosis. A controlled study. Chest 1992 1.39
9 Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis 2008 1.32
10 Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 1996 1.27
11 Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med 2004 1.13
12 B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med 2001 1.13
13 Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology 2001 1.12
14 Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum 1996 0.94
15 Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol 2011 0.94
16 Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation. Eur J Neurol 2010 0.92
17 Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients. J Chemother 2003 0.91
18 Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol 2009 0.90
19 The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J 1994 0.89
20 Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV. J Infect 1994 0.86
21 Cutaneous vasculitis associated with mixed cryoglobulinemia in adult Still's disease. Clin Exp Rheumatol 2003 0.86
22 Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation. J Eur Acad Dermatol Venereol 2011 0.86
23 Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int J Tuberc Lung Dis 2006 0.86
24 Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement. Rheumatology (Oxford) 2004 0.85
25 Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations. J Rheumatol 1996 0.84
26 Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis. Clin Diagn Lab Immunol 1997 0.84
27 Tuberculosis of the sacroiliac joint. Eur Spine J 1997 0.82
28 Lung scintigraphy with nonspecific human immunoglobulin G ((99m)Tc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT). Eur J Nucl Med Mol Imaging 2007 0.82
29 Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan's syndrome. Clin Rheumatol 1994 0.81
30 Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1993 0.81
31 Prevalence of diabetes mellitus and obesity in the general adult population of Greece: a door-to-door epidemiological study. Diabet Med 2009 0.81
32 Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study. Rheumatology (Oxford) 2008 0.80
33 Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol 2013 0.80
34 Immune cell signaling aberrations in human lupus. Immunol Res 1998 0.80
35 Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy. Clin Immunol Immunopathol 1997 0.79
36 CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition. Lupus 2002 0.79
37 13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor. Leuk Lymphoma 2003 0.78
38 Are clusters of patients with distinct clinical expression present in Behçet's disease? Clin Exp Rheumatol 2009 0.78
39 Increased levels of intercellular adhesion molecule 1 in patients with systemic lupus erythematosus: comment on the article by Mason et al. Arthritis Rheum 1994 0.78
40 Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy. Ann Rheum Dis 2008 0.77
41 Gene therapy in systemic lupus erythematosus. Curr Gene Ther 2005 0.77
42 Absence of p53 gene mutations in skin fibroblasts derived from patients with systemic sclerosis. Eur J Clin Invest 2002 0.77
43 Molecular and immunohistochemical study of class I growth factor receptors in squamous cell lung carcinomas. Pathol Res Pract 1995 0.77
44 Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1995 0.77
45 The effect of diabetes mellitus on the prevalence of rheumatoid arthritis: a case-control study. Diabet Med 2008 0.77
46 Clinical and laboratory parameters in adult diabetics with and without calcific shoulder periarthritis. Calcif Tissue Int 1991 0.76
47 Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med 1991 0.76
48 Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis. Clin Immunol 2013 0.76
49 Glucocorticoid effects on myocardial performance in patients with systemic sclerosis. Clin Exp Rheumatol 2001 0.75
50 Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease. Clin Exp Rheumatol 2007 0.75
51 Gout and neurological abnormalities associated with cardiomyopathy in a young man. Ann Rheum Dis 1990 0.75
52 Twenty-four hours urinary hydroxyproline excretion in long-term experimental diabetes mellitus. Horm Metab Res 1993 0.75
53 Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosis. Clin Exp Rheumatol 2012 0.75
54 Adamantiadis-Behçet's disease in sisters. Clin Rheumatol 1996 0.75
55 Why is p53-inducible gene 3 rarely affected in cancer? Oncogene 2010 0.75
56 Personal characteristics may affect evaluation of teaching: a prospective study in medical students. Med Teach 2013 0.75
57 Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis. Lung Cancer 2000 0.75
58 Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study. Exp Clin Endocrinol Diabetes 1998 0.75
59 Tuberculosis after anti-TNF therapy: a continuous learning process. Scand J Rheumatol 2012 0.75